> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-225/
- Published: 2019-05-27T12:00:00.000Z
- Updated: 2026-09-15T01:28:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144201

[**Regulatory Review Period for Edwards Aortic Valve**](https://www.fdaweb.com/regulatory-review-period-for-edwards-aortic-valve/)  
*Federal Register* notice: FDA determines that the regulatory review period for Edwards Lifesciences’ Edwards Intuity Elite Aortic Valve is 1,508 days. 05/24/2019

[**Final Guide on Compounding Bulks List**](https://www.fdaweb.com/final-guide-on-compounding-bulks-list/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Section 503A Bulks List Final Rule Questions and Answers.” 05/24/2019

[**General Surgery Device Panel Meeting Amended**](https://www.fdaweb.com/general-surgery-device-panel-meeting-amended/)  
*Federal Register* notice: FDA announces an amendment to a 4/24 Federal Register notice about a 5/30-31 General and Plastic Surgery Devices Panel meeting. 05/23/2019

[**Therapeutic Protein Biosimilars Draft Guide**](https://www.fdaweb.com/therapeutic-protein-biosimilars-draft-guide/)  
*Federal Register* notice: FDA posts a draft guidance on “Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Other Quality-Related Considerations.” 05/22/2019

[**24 No-Longer-Marketed ANDAs Withdrawn**](https://www.fdaweb.com/24-no-longer-marketed-andas-withdrawn/)  
*Federal Register* notice: FDA withdraws approval of 24 ANDAs from multiple applicants. 05/22/2019

[**Info Collection Extension for Exports: Notification and Recordkeeping**](https://www.fdaweb.com/info-collection-extension-for-exports-notification-and-recordkeeping/)  
*Federal Register* notice: FDA submits to OMB an information collection extension for “Exports: Notification and Recordkeeping Requirements — 21 CFR 1.101.” 05/20/2019

[**FDA Reorganizes Headquarters Organizations and Product Centers**](https://www.fdaweb.com/fda-reorganizes-headquarters-organizations-and-product-centers/)  
*Federal Register* notice: FDA announces it has modified organizational structures in the Office of the Commissioner, headquarters organizations, and product Centers. 05/20/2019

[**Info Collection Extension for Drug Patent Listings**](https://www.fdaweb.com/info-collection-extension-for-drug-patent-listings/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Applications for Food and Drug Administration Approval to Market a New Drug: Patent Submission and Listing Requirements.” 05/17/2019